Radiobromine production, isolation and radiosynthesis for the development of a novel prostate cancer radiotherapeutic agent

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The radioactive isotopes of bromine accessible with low energy medical cyclotrons have unique potential for diagnostic and radiotherapeutic nuclear medicine applications. These include bromine-76 (t1/2 = 16 h) for positron emission tomography and bromine-77 (t1/2 = 57 h) for Auger radionuclide therapy. Methods are presented to synthesize NiSe discs from elemental starting materials for proton irradiation in a 4π water cooling target configuration. Radiobromide was isolated from the irradiated NiSe material by dry distillation and used to radiolabel 7α-BrDHT for investigation as an Androgen-receptor-targeted theranostic radiopharmaceutical.

Cite

CITATION STYLE

APA

Ellison, P. A., Graves, S. A., Murali, D., De Jesus, O. T., Barnhart, T. E., Thomadsen, B. R., … Nickles, R. J. (2017). Radiobromine production, isolation and radiosynthesis for the development of a novel prostate cancer radiotherapeutic agent. In AIP Conference Proceedings (Vol. 1845). American Institute of Physics Inc. https://doi.org/10.1063/1.4983538

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free